Pharmafile Logo
Pharmafocus logo
Advanced Search

UCB appoints Peter Theil as head of non-clinical development

November 28, 2011
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing UCB

Peter Theil has joined UCB as its new vice president and head of non-clinical development for the firm’s new medicines …

Appointment

Pfizer to acquire skin specialist firm Excaliard

November 28, 2011
Sales and Marketing EXC 001, Excaliard, Pfizer

Pfizer will acquire skin specialist Excaliard Pharmaceuticals as the firm looks to further diversify its pipeline. Financial terms of the …

News

Shire facility could answer rare disease drug shortage

November 27, 2011
Manufacturing and Production Fabry disease, Gaucher, Shire, Vpriv

Shire has filed applications with the European and US regulators to produce its Gaucher disease drug Vpriv (velaglucerase alfa) at …

News

Pfizer’s Loughbeg first pharma facility to meet green standard

November 27, 2011
Manufacturing and Production ISO 50001, Loughbeg, Pfizer, environmental

A Pfizer facility in Ireland has become the first pharmaceutical plant in the world to meet a tough new standard …

News

The changing of the guard – Q3 round up

November 25, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lipitor, Q3, Ranbaxy

 PfizerOf all the patent cliffs in pharma, Lipitor’s expiry represents the biggest. Pfizer is now staring over the precipice, with …

Feature

Quality fears prompt cancer drug recalls

November 25, 2011
Manufacturing and Production Ben Venue, EU, Hong Kong, manufacturing

Regulatory authorities around the world are recalling cancer drugs manufactured by Boehringer Ingelheim’s Ben Venue Laboratories subsidiary after an inspection …

News

Mixed results for UK in international health survey

November 25, 2011
Sales and Marketing NHS, OECD, healthcare

The NHS in England does not perform well on some patient outcomes for cancer, stroke and respiratory diseases given the …

News
NICE hq pic

NICE okays Eliquis for blood clots after surgery

November 25, 2011
Research and Development, Sales and Marketing BMS, Eliquis, NICE, Pfizer

NICE is recommending Pfizer and Bristol-Myers Squibb’s Eliquis for blood clots after surgery. Specifically, NICE has said that Eliquis (apixaban) …

News
screen_shot_2011-11-24_at_13

RSA announces raft of new appointments

November 24, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

RSA, the global life sciences executive search and interim management firm, has announced a series of new appointments. RSA Switzerland …

Appointment

Adaptive Trial Design

November 24, 2011
Research and Development

Despite the burgeoning interest in Adaptive Trial Design (ATD), an extremely powerful tool when used effectively in the appropriate circumstances, …

Feature
White paper

NICE confirms ‘no’ for colorectal cancer drugs

November 24, 2011
Sales and Marketing Erbitux, NICE, Vectibix, avastin, colorectal cancer

 

News
glyn_edwards

Glyn Edwards appointed interim chief executive of the BioIndustry Association

November 24, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, Glyn Edwards

The BioIndustry Association (BIA) has appointed Glyn Edwards as its interim chief executive effective immediately. Edwards was previously chief executive …

Appointment
Lucentis image

Lucentis not backed by NICE for new licence

November 24, 2011
Sales and Marketing Lucentis, NICE, Novartis, Ozurdex

NICE has not recommended Novartis’ eye disease drug Lucentis due to ‘gaps and uncertainties’ in the manufacturer’s submission. In draft …

News
screen_shot_2011-11-24_at_09

Professor Sir Michael Rawlins reappointed as NICE chairman

November 24, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, Rawlins

The National Institute for Health and Clinical Excellence (NICE) has reappointed Professor Sir Michael Rawlins as NICE chairman for a …

Appointment

Private sector role in NHS commissioning opposed

November 23, 2011
Medical Communications, Sales and Marketing BMA, CCGs, NHS, PCT clusters

Private firms could be allowed to support clinical commissioning groups, the new NHS budget holders in England.New draft guidance from the Department …

News

Future of public health uncertain, says Forum

November 23, 2011
Sales and Marketing Future Forum, NHS, NHS reforms

The Department of Health has been urged to clarify the NHS’s responsibilities in relation to public health.The independent NHS Future …

News
Alasdair Williams

Red Door launches Grapevine ‘localisation’ service

November 23, 2011
Medical Communications Grapevine, Red Door

 Red Door Communications has launched Grapevine – a new healthcare ‘localisation’ initiative and appointed Alasdair Williams as its head. Grapevine …

News

Pfizer hatches mail order plan for Lipitor

November 23, 2011
Sales and Marketing Lipitor, Pfizer, US, generics

Pfizer is preparing to launch a new mail order service offering cut-price Lipitor direct to patients in the US.The firm …

News

Big pharma counts cost of R&D decline

November 23, 2011
Research and Development Deloitte, GSK, IIR, R&D productivity

Leading pharma firms are getting around 30% less on their investments in research and development compared to last year, according …

News
Vioxx

Merck pays $950 million to settle Vioxx charges

November 23, 2011
Sales and Marketing Department of Justice, Merck, Vioxx, marketing violations, off label marketing

Merck will pay out $950 million and admit that it illegally marketed its painkiller Vioxx in the US. It will …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026